Mindray Medical (MR) Reports Q3 Adj-EPS of $0.33, Beats by 6c
Mindray Medical International LTD (NYSE: MR) reports Q3 EPS of $0.33, ex-items, 6 cents better than the analyst estimate of $0.27.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Rue21, Inc. (RUE) Tops Q1 EPS by 3c; Boosts FY12 EPS Outlook; Approves $50M Buyback
- NetApp (NTAP) Slammed On Weak Outlook
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
